Veterinary World

     Open access and peer reviewed journal  

ISSN (Online): 2231-0916


Home l Editorial board l Instructions for authors l Reviewer guideline l Open access policy l Archives l FAQ

Open Access

Research (Published online: 14-02-2017)

9. Preparation of mucosal nanoparticles and polymer-based inactivated vaccine for Newcastle disease and H9N2 AI viruses - Heba M. El Naggar, Mohamed Sayed Madkour and Hussein Ali Hussein

Veterinary World, 10(2): 187-193



   doi: 10.14202/vetworld.2017.187-193


Heba M. El Naggar: Department of Poultry Vaccines Production Unit Veterinary Serum and Vaccine Research Institute, Abbasia 11759, Egypt.

Mohamed Sayed Madkour: Department of Poultry Vaccines Production Unit Veterinary Serum and Vaccine Research Institute, Abbasia 11759, Egypt.

Hussein Ali Hussein: Department of Virology, Faculty of Veterinary Medicine, Cairo University, Giza 12211, Egypt.


Received: 22-08-2016, Accepted: 10-01-2017, Published online: 14-02-2017


Corresponding author: Hussein Ali Hussein,

Citation: El Naggar HM, Madkour MS, Hussein HA (2017) Preparation of mucosal nanoparticles and polymer-based inactivated vaccine for Newcastle disease and H9N2 AI viruses, Veterinary World, 10(2): 187-193.

Aim: To develop a mucosal inactivated vaccines for Newcastle disease (ND) and H9N2 viruses to protect against these viruses at sites of infections through mucosal immunity.

Materials and Methods: In this study, we prepared two new formulations for mucosal bivalent inactivated vaccine formulations for Newcastle and Avian Influenza (H9N2) based on the use of nanoparticles and polymer adjuvants. The prepared vaccines were delivered via intranasal and spray routes of administration in specific pathogen-free chickens. Cell-mediated and humoral immune response was measured as well as challenge trial was carried out. In addition, ISA71 water in oil was also evaluated.

Results: Our results showed that the use of spray route as vaccination delivery method of polymer and nanoparticles MontanideTM adjuvants revealed that it enhanced the cell mediated immune response as indicated by phagocytic activity, gamma interferon and interleukin 6 responses and induced protection against challenge with Newcastle and Avian Influenza (H9N2) viruses.

Conclusion: The results of this study demonstrate the potentiality of polymer compared to nanoparticles adjuvantes when used via spray route. Mass application of such vaccines will add value to improve the vaccination strategies against ND virus and Avian influenza viruses.

Keywords: adjuvant, H9N2, mucosal, nanoparticles, Newcastle, polymer.

1. Naeem, K., Ullah, A., Manvell, R.J. and Alexander, D.J. (1999) Avian influenza A subtype H9N2 in poultry in Pakistan. Vet. Rec., 145: 560.
2. Bano, S., Naeem, K. and Malik, S.A. (2003) Evaluation of pathogenic potential of avian influenza virus serotype H9N2 in chickens. Avian Dis., 47: 817-822.
3. Capua, I. and Aalxander, D.J. (2004) Avian influenza: Recent developments. Avian Pathol., 33: 393-404.
4. Guo, Y.J., Krauss, S., Senne, D.A., Mo, I.P., Lo, K.S., Xiong, X.P., Orwood, M., Shortridge, K.F., Webster, R.G. and Guan, Y. (2000) Characterization of the pathogenicity of members of the newly established H9N2 influenza virus lineages in Asia. Virology, 267(2): 279-288.
5. Hussien, H.A. and Elazab, M. (2001) Evidence for the presence of H6 and H9 among broiler and layer breeders in Egypt. Proceedings XII International Congress World Veterinary Poultry Association, Cairo-Egypt. p227-235.
6. Arafa, A., Hagag, N., Erfan, A., Mady, W., El-Husseiny, M., Adel, A. and Nasef, S. (2012) Complete genome characterization of avian influenza virus subtype H9N2 from a commercial quail flock in Egypt. Virus Genes, 45: 283-294.
7. El-Zoghby, E.F., Arafa, A.S., Hassan, M.K., Aly, M.M., Selim, A., Kilany, W.H., Selim, U., Nasef, S., Aggor, M.G., Abdelwhab, E.M. and Hafez, H.M. (2012) Isolation of H9N2 avian influenza virus from bobwhite quail (Colinus virginianus) in Egypt. Arch. Virol., 157(6): 1167-1172.
8. Ekiert, D.C., Friesen, R.H., Bhabha, G., Kwaks, T., Jongeneelen, M., Yu, W., Ophorst, C., Cox, F., Korse, H.J., Brandenburg, B., Vogels, R., Brakenhoff, J.P., Kompier, R., Koldijk, M.H., Cornelissen, L.A., Poon, L.L., Peiris, M., Koudstaal, W., Wilson, I.A. and Goudsmit, J. (2011) A highly conserved neutralizing epitope on group 2 influenza a virus. Science, 333: 843-850.
PMid:21737702 PMCid:PMC3210727
9. Wei, T.C., Wei, P., Li, H.Q., He, C.W., Mo, M.L., Liu, L. and Chen, X. (2012) Molecular and genetic analysis of isolates of Newcastle disease virus of different poultry species origins during 1999-2012 in Guangxi, China. WVPAC, Nantes France.
10. Diel, D.G., da Silva, L.H.A., Liu, H., Wang, Z. and Miller, P.J. (2012) Genetic diversity of avian paramyxovirus Type 1: Proposal for a unified nomenclature and classification system of Newcastle disease virus genotypes. Infect. Genet. Evol., 12: 1770-1779.
11. Li, J., Hu, H., Yu, Q., Diel, D.G., Li, D.S. and Miller, P.J. (2012) Generation and characterization of a recombinant Newcastle disease virus expressing the red fluorescent protein for use in co-infection studies. J. Virol., 9: 227.
PMid:23034005 PMCid:PMC3502164
12. Huang, Y., Wan, H.Q., Liu, H.Q., Wu, Y.T. and Liu, X.F. (2004) Genomic sequence of an isolate of Newcastle disease virus isolated from an outbreak in geese: A novel six nucleotide insertion in the non-coding region of the nucleoprotein gene. Arch. Virol., 149(7): 1445-1457.
13. Radwan, M.M., Darwish, S.F., El-Sanousi, A.A. and Shalaby, M.A. (2013) Isolation and molecular characterization of Newcastle disease virus genotypes in Egypt between 2011 and 2012. Virus Genes, 47(2): 311-316.
14. Amer, M.M., Wafaa, A. and El-Ghany, A. (2006) The effect of different Newcastle disease live vaccines and vaccination schedules on the immune response and performance of broiler chickens serologically positive to Mycoplasma. Beni-Suef Vet. Med. J., 16(1): 18-26.
15. Hussein, H.A., Emara, M.M., Samy, A.M. and Shalaby, M.A. (2000) Antigenic diversity of Newcastle disease virus isolated from 52 breeder and broiler flocks in Egypt. Egypt. J. Immune Vet., 2: 3-15.
16. Hassan, M.K., Afifi, M.M. and Ali, M.M. (2004) Genetic resistance of Egyptian chicken to infectious bursal disease and Newcastle diseases viruses. Trop. Anim. Health Prod., 36(1): 111-119.
17. Hussein, H.A., El-Sanousi, A.A., Youssif, A.A., Shalaby, M.A., Saber, M.S. and Reda, I.M. (2005) Sequence analysis of fusion and matrix protein genes of the velogenic viscerotropic Newcastle disease virus. Int. J. Virol., 1(1): 38.
18. Hussein, H.A., Emara, M.M. and Rohaim, M.A. (2014) Molecular characterization of Newcastle disease virus genotype VIID in avian influenza H5N1 infected broiler flock in Egypt. Int. J. Virol., 10(1): 46.
19. Kang, S.M., Guo, L., Yao, Q., Skountzou, I. and Compans, R.W. (2004) Intranasal immunization with inactivated influenza virus enhances immune responses to coadministered simian-human immunodeficiency virus-like particle antigens. J. Virol., 78: 9624-9632.
PMid:15331695 PMCid:PMC514968
20. Armerding, D., Rossiter, H., Ghazzouli, I. and Liehl, E. (1982) Evaluation of live and inactivated influenza A virus vaccines in a mouse model. J. Infect. Dis., 145: 320-330.
21. Sha, Z. and Compans, R.W. (2000) Induction of CD4 T-cell-independent immunoglobulin responses by inactivated influenza virus. J. Virol., 74: 4999-5005.
PMid:10799573 PMCid:PMC110851
22. Takada, A., Matsushita, S., Ninomiya, A., Kawaoka, Y. and Kida, H. (2003) Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice. Vaccine, 21: 3212-3218.
23. Tamura, S.I., Asanuma, H., Ito, Y., Hirabayashi, Y., Suzuki, Y., Nagamine, T., Aizawa, C., Kurata, T. and Oya, A. (1992) Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine. Eur. J. Immunol., 22: 477-481.
24. Tumpey, T.M., Renshaw, M., Clements, J.D. and Katz, J.M. (2001) Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection. J. Virol., 75: 5141-5150.
PMid:11333895 PMCid:PMC114919
25. de Geusa, E.D., van Haarlema, D.A., Poetria, O.N., de Wit, J.J. and Vervelde, L. (2011) A lack of antibody formation against inactivated influenza virus after aerosol vaccination in presence or absence of adjuvantia. Vet. Immunol. Immunopathol., 143: 143-147.
26. de Wit, J.J., Swart, W.A. and Fabri, T.H. (2010) Efficacy of infectious bronchitis virus vaccinations in the field: Association between the alpha-IBV IgM response, protection and vaccine application parameters. Avian Pathol., 2: 123-131.
27. Ley, D.H. (2003) Mycoplasmosis. In: Saif, Y.M., Barnes, H.J., Glission, J.R., Fadly, A.M., McDougald, L.R., Swayne, D.E., editors. Diseases of Poultry. Iowa State University Press, Ames, IA. p722-744.
28. Atmar, R.L., Keitel, W.A., Cate, T.R., Munoz, F.M., Ruben, F. and Couch, R.B. (2007) A dose-response evaluation of inactivated influenza vaccine given intranasally and intramuscularly to healthy young adults. Vaccine, 29: 5367-5373.
PMid:17559990 PMCid:PMC2063441
29. Worrall E.E., Sudarisman, Priadi A. (2009) Sialivac: An intranasal homologous inactivated split virus vaccine containing bacterial sialidase for the control of avian influenza in poultry. Vaccine, 31: 4161-4168.
30. Kapczynski, D.R., Afonso, C.L. and Miller, P.J. (2013) Immune responses of poultry to Newcastle disease virus. Dev. Comp. Immunol., 41: 447-453.
31. Akbari, O., DeKruyff, R.H. and Umetsu, D.T. (2001) Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat. Immunol., 8: 725-731.
32. Hagenaars, N., Mastrobattista, E., Glansbeek, H., Heldens, J., van den Bosch, H., Schijns, V., Betbeder, D., Vromans, H. and Jiskoot, W. (2008) Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: Effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model. Vaccine, 26: 6555-6563.
33. Tseng, L.P., Chiou, C.J., Chen, C.C., Deng, M.C., Chung, T.W., Huang, Y.Y. and Liu, D.Z. (2009) Effect of lipopolysaccharide on intranasal administration of liposomal Newcastle disease virus vaccine to SPF chickens. Vet. Immunol. Immunopathol., 3-4: 285-289.
34. Riffault, S., Meyer, G., Deplanche, M., Dubuquoy, C., Durand, G., Soulestin, M., Castagné, N., Bernard, J., Bernardet, P., Dubosclard, V., Bernex, F., Petit-Camurdan, A., Deville, S., Schwartz-Cornil, I. and Eléouët, J.F. (2010) A new subunit vaccine based on nucleoprotein nanoparticles confers partial clinical and virological protection in calves against bovine respiratory syncytial virus. Vaccine, 28: 3722-3734.
35. Deville, S., Arous, J.B., Bertrand, F., Borisov, V. and Dupuis, L. (2012) Efficacy of intranasal and spray delivery of adjuvanted live vaccine against infectious bronchitis virus in experimentally infected poultry. Procedia Vaccinol., 6: 85-92.
36. Branton, S.L., Roush, W.B., Lot, B.D., Evans, J.D., Dozier, W.A., Collier, S.D., Bearson, S.M., Bearson, B.L. and Pharr, G.T. (2005) A self propelled constant-speed spray vaccinator for commercial layer chicken. Avian Dis., 49: 147-151.
37. Jang, S.I., Lillehoj, H.S., Lee, S.H., Lee, K.W., Lillehoj, E.P., Bertrand, F., Dupuis, L. and Deville, S.(2011) Montanide™ IMS 1313 N VG PR nanoparticle adjuvant enhances antigen-specific immune responses to profilin following mucosal vaccination against Eimeria acervulina. Vet. Parasitol., 182: 163-170.
38. Corbanie, E.A., Matthijs, M.G., van Eck, J.H., Remon, J.P., Landman, W.J. and Vervaet, C. (2006) Deposition of differently sized airborne microspheres in the respiratory tract of chickens. Avian Pathol., 35: 475-485.
39. Shakya, A.K. and Nandakumar, K.S (2012) Applications of Polymeric Adjuvants in Studying Autoimmune Responses and Vaccination against Infectious Diseases. J R Society Interface 10: 20120536. Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.
PMid:23173193 PMCid:PMC3565688
40. Deville, S. and Parker, R. (2008) Laval A. - Adjuvant formulation for influenza H1N1 and H3N2 pig vaccines. Montanide™ Gel safety and efficacy study. Proceedings of the Conference of Research of Workers in Animal Diseases, Chicago.
41. Purswell, J.L., Mayer, J.J., Evans, J.D., Branton, S.L. and Davis, J.D. (2012) Eye surface area and dosage rates for spray vaccination. Avian Dis., 54: 1310-1315.
42. Hu, Z., Hu, J., Hu, S., Liu, X., Wang, X., Zhu, J. and Liu, X. (2012) Strong innate immune response and cell death in chicken splenocytes infected with genotype VIId Newcastle disease virus. Virol. J., 9: 208.
PMid:22988907 PMCid:PMC3489799
43. Katze, M.G., He, Y. and Gale, M.Jr. (2002) Viruses and interferon: A fight for supremacy. Nat. Rev. Immunol., 2(9): 675-687.
44. Lienenluke, B. and Christ, B. (2007) Impact of interleukin-6 on the glucose metabolic capacity in rat liver. Histochem. Cell Biol., 128(4): 371-377.
45. Mizuguchi, M., Yamanouchi, H., Ichiyama, T. and Shiomi, M. (2007) Acute encephalopathy associated with influenza and other viral infections. Acta Neurol. Scand., 115(4): 45-56.
46. Ichinohe, T., Watanabe, I., Tao, E., Ito, S., Kawaguchi, A., Tamura, S., Takahashi, H., Sawa, H., Moriyama, M., Chiba, J., Komase, K., Suzuki, Y., Kurata, T., Sata, T. and Hasegawa, H. (2006) Protection against influenza virus infection by intranasal vaccine with surf clam microparticles (SMP) as an adjuvant. J. Med. Virol., 7: 954-963.
47. Joo, H.M., He, Y., Sundararajan, A., Huan, L. and Sangster, M.Y. (2010) Quantitative analysis of influenza virus-specific B cell memory generated by different routes of inactivated virus vaccination. Vaccine, 28(10): 2186-2194.
48. Rice-Ficht, A.C., Arenas-Gamboa, A.M., Kahl-McDonagh, M.M. and Ficht, T.A. (2009) Polymeric particles in vaccine delivery. Curr. Opin. Microbiol., 13(1): 106-112.
49. Thomasin, C., Corradin, G., Men, Y., Merkle, H.P. and Gander, B. (1996) Tetanus toxoid and synthetic malaria antigen containing poly(lactide)/poly(lactide-co-glycolide) microspheres: Importance of polymer degradation and antigen release for immune response. J. Controlled Release, 41(1-2): 131-145.
50. Karpala, A.J., Bingham, J., Schat, K.A., Chen, L.M., Donis, R.O., Lowenthal, J.W. and Bean, A.G. (2011) Highly pathogenic (H5N1) avian influenza induces an inflammatory T helper Type 1 cytokine response in the chicken. J. Interferon Cytokine Res., 31(4): 393-400.
51. Adams, S.C., Xing, Z., Li, J.L. and Cardona, C.J. (2009) Immune-related gene expression in response to H11N9 low pathogenic avian influenza virus infection in chicken and Pekin duck peripheral blood mononuclear cells. Mol. Immunol., 46(8): 1744-1749.
52. HogenEsch, H. (2002) Mechanisms of stimulation of the immune response by aluminum adjuvants. Vaccine, 20 Suppl 3: S34-S39.
53. Adams, J.R., Haughney, S.L. and Mallapragada, S.K. (2014) Effective polymer adjuvants for sustained delivery of protein subunit vaccines. Acta Biomater.14:104-114.
54. Susta, L., Hamel, K.R., Miller, P.J., Garcia, S.C., Brown, C.C., Pedersen, J.C., Gongora, V. and Afonso, C.L. (2012) Separate evolution of virulent Newcastle disease viruses from Mixico and Central American. J. Clin. Microbiol., 52: 1382-1390.
PMid:24523463 PMCid:PMC3993629
55. Fentie, T., Dadi, K., Kassa, T., Sahle, M. and Cattoli, G. (2014) Effect of vaccination on transmission characteristics of highly virulent Newcastle disease virus in experimentally infected chickens. Avian Pathol., 43(5): 420-426.
56. Damen, D., Fusaro, A., Sombo, M., Belaineh, R., Heidari, A., Kebede, A., Kidane, M. and Chaka, H. (2016) Characterization of Newcastle disease virus isolates obtained from outbreak cases in commercial chickens and wild pigeons in Ethiopia. Springerplus, 5: 476.
PMid:27217991 PMCid:PMC4835400